Comprehensive mutation analysis in NRG Oncology/RTOG 9813: A phase III trial of RT plus TMZ vs RT plus nu for anaplastic astrocytoma and mixed anaplastic oligoastrocytoma (Astrocytoma Dominant). Conference

Bell, Erica Hlavin, McElroy, Joseph P, Fleming, Jessica et al. (2016). Comprehensive mutation analysis in NRG Oncology/RTOG 9813: A phase III trial of RT plus TMZ vs RT plus nu for anaplastic astrocytoma and mixed anaplastic oligoastrocytoma (Astrocytoma Dominant). . JOURNAL OF CLINICAL ONCOLOGY, 34(15), 10.1200/JCO.2016.34.15_suppl.2016

cited authors

  • Bell, Erica Hlavin; McElroy, Joseph P; Fleming, Jessica; Timmers, Cynthia Dawn; Chakraborty, Arup R; Salavaggione, Andrea L; Chang, Susan Marina; Aldape, Kenneth D; Brachman, David; Shih, Helen Alice; Zhang, Peixin; Mehta, Minesh P; Chakravarti, Arnab

authors

date/time interval

  • June 3, 2016 -

publication date

  • May 20, 2016

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Chicago, IL

Digital Object Identifier (DOI)

Conference

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 34

issue

  • 15